Clinical TrialsSearch results
Number of results: 658
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A non-randomized confirmatory study of Limited Surgical Resection for Peripheral Early Lung Cancer Defined with Thoracic Thin-section Computed Tomography (JCOG0804/WJOG4507L)
- small (2 cm or less) peripheral radiological non-invasive lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2009-05-26
Recruiting
- A Phase 1 Study of Lomustine and PCV in Japanese Patients with Glioma
- Glioma
- ARAKAWA Yoshiki
- 2023-07-19
Recruiting
- A Phase 1, Open-label, Dose Finding Study of CC-93269, a BCMA x CD3 T Cell Engaging Antibody, in Subjects with Relapsed and Refractory Multiple Myeloma
- Relapsed and refractory multiple myeloma
- Hayakawa Jin
- 2023-10-04
Other
- A phase 2 neoadjuvant chemotherapy of Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage 1b2 or 2 cervical cancer of the uterine cervix
- stage 1b2/2 cervical cancer
- Japanese Gynecologic Oncology Group
- 2006-12-21
Other
- A phase 2 study for intermediate risk neuroblastoma based on IDRF (Image Defined Risk Factors)
- neuroblastoma
- iehara tomoko
- 2019-03-27
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Sulfonylurea
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to an Alpha-Glucosidase Inhibitor
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2008-10-01
Other
- A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab Monotherapy in Moderate-to-severe AD
- Atopic Dermatitis
- Chen Sarah
- 2023-04-03
Recruiting
- A PHASE 3, TWO-STAGE, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY COMPARING IBERDOMIDE, DARATUMUMAB AND DEXAMETHASONE (IberDd) VERSUS DARATUMUMAB, BORTEZOMIB, AND DEXAMETHASONE (DVd) IN SUBJECTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) (EXCALIBER-RRMM)
- Relapsed or refractory multiple myeloma (RRMM)
- Kimura Shunsuke
- 2021-07-01
Other
- A phase I trial of unrelated bone marrow transplantation for adult T cell leukemia/lymphoma following reduced intensity conditioning regimen.
- Adult T cell leukemia/lymphoma
- Grant for anticancer project from Ministry of Health, Welfare, and Labor of Japan.
- 2008-09-08